Literature DB >> 3751285

Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo.

R Raju, D Kolakofsky.   

Abstract

The effect of drugs such as puromycin and cycloheximide, which inhibit protein synthesis, on the accumulation of La Crosse virus S genome RNAs in vivo has been examined. We have found that if these drugs are added to the cultures before infection, minuscule amounts of S-mRNA can be detected late in infection. Genome replication, on the other hand, cannot be detected at any time. When these drugs are added later in infection when RNA synthesis is well established, S-mRNA accumulation decreases in a dose-dependent manner proportional to the effect of these drugs on protein synthesis. This decrease cannot be accounted for by increased turnover of the mRNA in the presence of the drug. S genome replication, curiously, was found to be hypersensitive to the effects of these drugs. Our results confirm those of Abraham and Pattnaik (1983) that ongoing protein synthesis is required for the accumulation of complete bunyavirus S-mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3751285     DOI: 10.1016/0168-1702(86)90061-4

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  The bunyavirus nucleocapsid protein is an RNA chaperone: possible roles in viral RNA panhandle formation and genome replication.

Authors:  M Ayoub Mir; Antonito T Panganiban
Journal:  RNA       Date:  2006-02       Impact factor: 4.942

4.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites.

Authors:  Mohammad A Mir; Sheema Sheema; Abdul Haseeb; Absarul Haque
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

6.  The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent.

Authors:  R Raju; L Raju; D Kolakofsky
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  La Crosse virus infection of mammalian cells induces mRNA instability.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease.

Authors:  Nilshad N Salim; Safder S Ganaie; Anuradha Roy; Subbiah Jeeva; Mohammad A Mir
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

9.  Interaction between hantavirus nucleocapsid protein (N) and RNA-dependent RNA polymerase (RdRp) mutants reveals the requirement of an N-RdRp interaction for viral RNA synthesis.

Authors:  Erdong Cheng; Zekun Wang; Mohammad A Mir
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

10.  Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.